BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22261145)

  • 41. Challenge by the murine brain: multi-pinhole SPECT of 123I-labelled pharmaceuticals.
    Pissarek MB; Oros-Peusquens AM; Schramm NU
    J Neurosci Methods; 2008 Mar; 168(2):282-92. PubMed ID: 18061274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.
    Yang YK; Yu L; Yeh TL; Chiu NT; Chen PS; Lee IH;
    Am J Psychiatry; 2004 Aug; 161(8):1496-8. PubMed ID: 15285982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to 11C-Raclopride PET.
    Bullich S; Cot A; Gallego J; Gunn RN; Suárez M; Pavía J; Ros D; Laruelle M; Catafau AM
    Neuroimage; 2010 May; 50(4):1511-8. PubMed ID: 20083205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity.
    van de Giessen E; Celik F; Schweitzer DH; van den Brink W; Booij J
    J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region.
    Pinborg LH; Videbaek C; Ziebell M; Mackeprang T; Friberg L; Rasmussen H; Knudsen GM; Glenthoj BY
    Neuroimage; 2007 Feb; 34(4):1450-3. PubMed ID: 17175177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
    Vessotskie JM; Kung MP; Chumpradit S; Romaniello G; McElgin W; Frederick D; Malison RT; Kung HF
    J Nucl Med; 1995 Jul; 36(7):1282-8. PubMed ID: 7790957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and Low-Avoidance Rats.
    Bellés L; Dimiziani A; Tsartsalis S; Millet P; Herrmann FR; Ginovart N
    Int J Neuropsychopharmacol; 2021 Mar; 24(3):239-251. PubMed ID: 33151278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.
    Schlösser R; Schlegel S
    J Neural Transm Gen Sect; 1995; 99(1-3):173-85. PubMed ID: 8579803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice.
    Meyer PT; Salber D; Schiefer J; Cremer M; Schaefer WM; Kosinski CM; Langen KJ
    Nucl Med Biol; 2008 Jul; 35(5):543-8. PubMed ID: 18589298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis.
    De Koning MB; Bloemen OJ; Van Duin ED; Booij J; Abel KM; De Haan L; Linszen DH; Van Amelsvoort TA
    J Psychopharmacol; 2014 Jun; 28(6):553-60. PubMed ID: 24526133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.
    Nikolaus S; Larisch R; Beu M; Vosberg H; Müller-Gärtner HW
    J Nucl Med; 2001 Nov; 42(11):1691-6. PubMed ID: 11696641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G; Tatsch K; Kraft E; Oertel WH; Schwarz J
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associations between dopamine D2 receptor availability and BMI depend on age.
    Dang LC; Samanez-Larkin GR; Castrellon JJ; Perkins SF; Cowan RL; Zald DH
    Neuroimage; 2016 Sep; 138():176-183. PubMed ID: 27208860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
    Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.